Taysha Gene Therapies Inc (TSHA)
3.09
-0.05
(-1.59%)
USD |
NASDAQ |
May 17, 16:00
3.08
-0.01
(-0.32%)
Pre-Market: 20:00
Taysha Gene Therapies Shares Outstanding: 187.02M for May 14, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
May 14, 2024 | 187.02M |
April 04, 2024 | 187.02M |
March 31, 2024 | 187.02M |
March 19, 2024 | 187.02M |
December 31, 2023 | 186.96M |
November 14, 2023 | 186.96M |
September 30, 2023 | 186.96M |
September 18, 2023 | 186.96M |
August 18, 2023 | 186.96M |
August 16, 2023 | 186.88M |
August 14, 2023 | 64.46M |
June 30, 2023 | 64.43M |
May 11, 2023 | 64.18M |
April 24, 2023 | 64.18M |
April 15, 2023 | 64.18M |
April 05, 2023 | 63.47M |
March 31, 2023 | 63.47M |
March 28, 2023 | 63.47M |
December 31, 2022 | 63.21M |
November 08, 2022 | 62.44M |
October 31, 2022 | 62.44M |
October 24, 2022 | 48.44M |
October 17, 2022 | 41.18M |
September 30, 2022 | 41.18M |
Date | Value |
---|---|
August 11, 2022 | 41.09M |
June 30, 2022 | 41.02M |
May 16, 2022 | 40.55M |
April 21, 2022 | 40.47M |
April 01, 2022 | 38.47M |
March 31, 2022 | 38.47M |
December 31, 2021 | 38.47M |
November 10, 2021 | 38.47M |
September 30, 2021 | 38.47M |
August 16, 2021 | 38.39M |
June 30, 2021 | 38.39M |
May 11, 2021 | 37.92M |
April 20, 2021 | 37.82M |
April 01, 2021 | 37.76M |
March 31, 2021 | 37.76M |
March 03, 2021 | 37.76M |
February 15, 2021 | 37.76M |
December 31, 2020 | 37.76M |
November 12, 2020 | 37.76M |
September 30, 2020 | 37.76M |
September 29, 2020 | 36.99M |
September 24, 2020 | 35.81M |
September 02, 2020 | 34.52M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
34.52M
Minimum
Sep 02 2020
187.02M
Maximum
Mar 19 2024
76.17M
Average
41.18M
Median
Sep 30 2022
Shares Outstanding Benchmarks
Aquestive Therapeutics Inc | 91.04M |
Lifecore Biomedical Inc | 30.55M |
Relmada Therapeutics Inc | 30.17M |
ACADIA Pharmaceuticals Inc | 165.22M |
Cyclacel Pharmaceuticals Inc | 1.318M |